Dr. Sun is the Founder and Chief Technical Officer at uBriGene Biosciences Inc. She is a seasoned healthcare executive with over 10 years of experience in the commercialization of viral vectors, research, drug development, and manufacturing. As the founder, she led the technical team to build GMP systems including GMP-compliant vectors construction for gene therapy, manufacturing and purification technology, cell line establishment and screening technology, etc. She also led the development of CAR-T technology, especially ICAR30 T cells for Hodgkin lymphoma, and filed an international patent application under the PCT to obtain independent protection of intellectual property. Previously, as co-founder and chief scientist of Vigene Biosciences Inc., Dr. Sun oversaw the commercialization of human gene banks and virus packaging platforms. Dr. Sun studied and worked at The School of Medicine, Nankai University, Institute of Hematology and Blood Diseases, Chinese Academy of Sciences and holds a PhD from the University of British Columbia (UBC), Faculty of Medicine. She is the recipient of the prestigious title of First Distinguished Taishan Scholar, for her contribution to scientific and technological innovations. She is the only member in Greater China amongst 14 members of USP AAV Expert Panel.
